VIMTALABS Stock Overview
Provides contract research and testing services in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Vimta Labs Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹550.90 |
52 Week High | ₹699.80 |
52 Week Low | ₹390.30 |
Beta | 0.75 |
11 Month Change | -1.13% |
3 Month Change | 14.66% |
1 Year Change | -1.96% |
33 Year Change | 97.95% |
5 Year Change | 414.62% |
Change since IPO | -39.36% |
Recent News & Updates
There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump
Sep 06It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package
Jul 12Recent updates
There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump
Sep 06It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package
Jul 12Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly
Jun 12Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost
Apr 26It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)
Jan 06If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity
Jul 14Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00
Jun 03Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00
May 06A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)
Dec 07Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today
Nov 06Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00
Jun 02Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?
Dec 06Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly
Oct 27We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now
Jun 29Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?
Jun 19Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly
Mar 09Vimta Labs Limited's (NSE:VIMTALABS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 20Did You Miss Vimta Labs' (NSE:VIMTALABS) 87% Share Price Gain?
Dec 30Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?
Dec 09Here's What We Learned About The CEO Pay At Vimta Labs Limited (NSE:VIMTALABS)
Nov 17Vimta Labs Limited's (NSE:VIMTALABS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Oct 21Here's Why Vimta Labs (NSE:VIMTALABS) Has A Meaningful Debt Burden
Sep 10Vimta Labs Limited's (NSE:VIMTALABS) Price Is Out Of Tune With Earnings
Aug 05Vimta Labs Limited's (NSE:VIMTALABS) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Jul 14Shareholder Returns
VIMTALABS | IN Life Sciences | IN Market | |
---|---|---|---|
7D | -3.9% | -1.4% | 1.6% |
1Y | -2.0% | 35.6% | 44.4% |
Return vs Industry: VIMTALABS underperformed the Indian Life Sciences industry which returned 36.1% over the past year.
Return vs Market: VIMTALABS underperformed the Indian Market which returned 45.2% over the past year.
Price Volatility
VIMTALABS volatility | |
---|---|
VIMTALABS Average Weekly Movement | 7.2% |
Life Sciences Industry Average Movement | 6.4% |
Market Average Movement | 6.3% |
10% most volatile stocks in IN Market | 9.3% |
10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: VIMTALABS has not had significant price volatility in the past 3 months.
Volatility Over Time: VIMTALABS's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 1,428 | Harita Vasireddi | vimta.com |
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies.
Vimta Labs Limited Fundamentals Summary
VIMTALABS fundamental statistics | |
---|---|
Market cap | ₹12.44b |
Earnings (TTM) | ₹410.91m |
Revenue (TTM) | ₹3.18b |
29.7x
P/E Ratio3.8x
P/S RatioIs VIMTALABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VIMTALABS income statement (TTM) | |
---|---|
Revenue | ₹3.18b |
Cost of Revenue | ₹889.32m |
Gross Profit | ₹2.29b |
Other Expenses | ₹1.88b |
Earnings | ₹410.91m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 18.53 |
Gross Margin | 71.99% |
Net Profit Margin | 12.94% |
Debt/Equity Ratio | 6.0% |
How did VIMTALABS perform over the long term?
See historical performance and comparison